1Lin KW,Kirchner JT.Hepatitis B[].American Family Physician.2004
2Lok AS,,Heathcot EJ,Hoofnagle JH.Management of hepatitis B:2000-summary of a workshop[].Gastroenterology.2001
3Lau GK,Piratvisuth T,Luo KX,et al.Peginterferon alfa-2a,lamivudi-ne,and the combination forHbeAg-positive chronic hepatitis B[].The New England Journal of Medicine.2005
4Marcellin P,Lau GK,Bonino F,et al.Peginterferon alfa-2a alone,lamivudine alone,and the two in combination in patientswith HBeAg negative chronic hepatitis B[].The New England Journal of Medicine.2004
5LiawYF,Leung NW,Chang TT,et al.Effects of extended lamivudine therapy in Asian patients with chronic hepatitis B.Asia Hepatitis Lamivudine Study Group[].Gastroenterology.2000
6Leung NW,Lai CL,Chang TT,et al.Extended lamivudine treatment in patients with chronic hepatitis B enhances hepatitis Be antigen se-roconversion rates:results after3years of therapy[].Hepatology.2001
7Hadziyannis SJ,Papatheodoridis GV,Dimou E,et al.Efficacy of long-term lamivudine monotherapy in patients with e antigen-negative chronic hepatitis B[].Hepatology.2000
8Gaia S,Marzano A,Smedile A,et al.Four years of treatment with lamivudine:clinical and virological evaluations in Hbe antigen-nega-tive chronic hepatitis B[].Alimentary Pharmacology and Therapeutics.2004
9Marcellin P,Chang TT,Lim SG,et al.Adefovir dipivoxil for the treatment of hepatitis B e antigen-positive chronic hepatitis B[].The New England Journal of Medicine.2003
10Hadziyannis SJ,Tassopoulos NC,Heathcote EJ,etal.Adefovirdipiv-oxil forthe treatmentof hepatitis Be antigen-negative chronic hepati-tis B[].The New England Journal of Medicine.2003
